Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PARANOID! TIRED OF TALKING TO YOURSELF? LET'S TALK(TTP) -- Ignore unavailable to you. Want to Upgrade?

To: Pseudo Biologist who wrote (28)	3/5/1998 12:38:00 PM
From: Arthur Radley	Read Replies (1) \| Respond to of 626

PB, I just took my own advise and called Sturza and subscribed for his trial subscription. They faxed me the report on TTNP. In his report he gives more attention to the upcoming Phase II trials of PIVANEX for non-small cell lung cancer; and its TriAB and CeaVAC cancer vaccines for the treatment of breast cancer and colon cancer. In my intro, I gave little information about this aspect of their business, but I think it significant that this isn't a one drug company, but one with research going on in two large market areas, cancer and nervous system disorders. With the aging population(me excluded), these are two major areas to be directing research(IMO).